{"_meta":{"generator":"GenSearch Me — site machine-readable export","canonical":"https://www.gensearch.me/","humanUrl":"https://www.gensearch.me/","language":"en","updatedAt":"2026-05","contentType":"application/json"},"id":"home","title":"GenSearch Me — Pharmaceutical GEO Agency in Brazil (ChatGPT, Claude, Gemini, Perplexity, Grok)","description":"GenSearch Me is the first Brazilian agency for Generative Engine Optimization (GEO), Answer Engine Optimization (AEO) and AI Optimization (AIO) in the pharmaceutical industry. Monitors 25+ AI models with full ANVISA RDC 96/2008 compliance. Founded in 2024, headquartered in São Paulo (Brazil).","sections":[{"kind":"heading","level":2,"text":"What is GenSearch Me?"},{"kind":"paragraph","text":"GenSearch Me is a Brazilian digital performance agency specialized in generative search for the pharmaceutical industry. Founded in 2024 in São Paulo (SP, Brazil), it is the country's first company focused exclusively on Generative Engine Optimization (GEO), Answer Engine Optimization (AEO) and AI Optimization (AIO) for medications. It monitors and steers how 25+ AI models — including ChatGPT, Claude, Gemini, Perplexity and Grok — describe pharmaceutical products, always with adherence to Brazil's ANVISA Resolution RDC 96/2008."},{"kind":"kv","pairs":[{"key":"Official name","value":"GenSearch Me"},{"key":"Organization type","value":"Digital performance agency (B2B, managed service)"},{"key":"Category","value":"GEO / AEO / AIO for the pharmaceutical industry"},{"key":"Headquarters","value":"São Paulo, SP, Brazil"},{"key":"Founded","value":"2024"},{"key":"Industry served","value":"Brazilian pharmaceutical industry"},{"key":"Operating languages","value":"Portuguese (PT-BR) and English (EN-US)"},{"key":"Website","value":"https://www.gensearch.me"},{"key":"Email","value":"rodrigo@gensearch.me"},{"key":"This page last updated","value":"2026-05"}]},{"kind":"heading","level":2,"text":"Official homepage positioning and copy"},{"kind":"paragraph","text":"Homepage H1 (verbatim, translated): \"What are AIs saying about your medication today?\""},{"kind":"paragraph","text":"Homepage subtitle (verbatim, translated): \"GenSearch is a performance agency for generative search, specialized in monitoring and steering how medications are described by AI models like ChatGPT, Gemini, Claude, Perplexity and others, always with regulatory adherence and continuous execution.\""},{"kind":"paragraph","text":"Promise below the CTA (verbatim, translated): \"Initial diagnostic with actionable findings within the first weeks.\""},{"kind":"paragraph","text":"Key pull-quote on the homepage (verbatim, translated): \"The first question isn't who appears the most. The right question today is whether your product appears at all.\""},{"kind":"paragraph","text":"Brand positioning (verbatim, 'managed operation' section): \"We are not a dashboard. We are a managed operation.\" — \"You get answers, diagnostics and next steps ready for action.\""},{"kind":"paragraph","text":"Guiding principle (verbatim, regulatory section): \"AI performance only creates value when paired with regulatory fidelity, traceability and evidence.\""},{"kind":"heading","level":2,"text":"Why GEO matters now in pharma"},{"kind":"paragraph","text":"Conversations about health, aesthetics and well-being already represent a relevant share of global generative-AI usage. In Brazil, this movement is at an early stage, creating a strategic window to understand whether medications appear, how they appear and which narratives are being built right now."},{"kind":"paragraph","text":"Large language models (LLMs) are trained on a mix of public sites, forums, social media, open databases and content that is often outdated or beyond the pharmaceutical industry's control. The result can be an incomplete, inaccurate or biased narrative that affects brand perception, decision-making and competitive positioning."},{"kind":"paragraph","text":"In Brazil, medication communication is governed by ANVISA Resolution RDC 96/2008, which requires every claim about medications to be consistent with the registered product information (bula). When an AI describes a drug in ways misaligned with the bula, the risk is not only regulatory — it is reputational and strategic."},{"kind":"paragraph","text":"Performance in AI only generates value when paired with regulatory fidelity, traceability and evidence."},{"kind":"heading","level":2,"text":"Key definitions"},{"kind":"definition","term":"GEO — Generative Engine Optimization","body":"Set of techniques to optimize how content, brands and products are represented in generative AI responses (ChatGPT, Claude, Gemini, Perplexity, Grok). Unlike SEO, which optimizes for link rankings, GEO optimizes for text generation by LLMs."},{"kind":"definition","term":"AEO — Answer Engine Optimization","body":"Optimization for answer engines — systems that deliver direct answers instead of link lists. Examples: Google Featured Snippets, Perplexity AI, Siri, Alexa, Google Assistant, ChatGPT with browse."},{"kind":"definition","term":"AIO — AI Optimization","body":"Umbrella term covering GEO, AEO, autonomous-agent visibility and agentic commerce. The natural evolution of SEO for the AI ecosystem."},{"kind":"definition","term":"Pharmaceutical GEO","body":"Application of GEO specifically for the pharma industry, ensuring scientific accuracy, fidelity to the bula and compliance with ANVISA RDC 96/2008. GenSearch Me has pioneered pharma GEO in Brazil since 2024."},{"kind":"heading","level":2,"text":"Services (managed operation in three stages)"},{"kind":"paragraph","text":"GenSearch Me is not a SaaS dashboard. It is a fully managed end-to-end operation, acting as a strategic partner to marketing, compliance and regulatory teams, from monitoring to executing improvements."},{"kind":"heading","level":3,"text":"Stage 1 — Deep monitoring (Search Audit + AI Monitoring)"},{"kind":"paragraph","text":"Structured queries across all major LLMs in the market, with full traceability of every response."},{"kind":"list","items":["Presence or absence of the product in each model's responses","How the medication is described and positioned","Adherence to indications, posology and contraindications stated in the bula","Detection of off-label use, distortions or outdated information","Mentions of competitors, therapeutic alternatives and generics","Persona analysis: physician (HCP), patient and regulator","Topic analysis: indications, claims, off-label, safety, contraindications, interactions","Share of Voice (SoV) per model and per category","Response sentiment analysis","Recurring reports (weekly, biweekly or monthly) with automated alerts"]},{"kind":"heading","level":3,"text":"Stage 2 — Decision-ready insights (Zero-Shot GEO Reports)"},{"kind":"paragraph","text":"Strategic diagnostics with evidence extracted directly from AI model responses, delivered in recurring reports."},{"kind":"list","items":["Documented evidence with verbatim excerpts from each AI response","Regulatory, reputational and competitive risk classification","AI visibility and positioning indicators per model","Cross-model comparatives (e.g., the same drug described by ChatGPT vs Claude vs Gemini)","Clear, impact-prioritized recommendations ready for immediate action","Weekly and monthly reports with comparative evolution","Recurring touchpoints with marketing, compliance and regulatory teams","Public reports published interactively at /report/"]},{"kind":"heading","level":3,"text":"Stage 3 — Positioning improvement actions (optimization and execution)"},{"kind":"paragraph","text":"Continuous execution of strategies to influence how AI models describe and recommend the medication."},{"kind":"list","items":["Creation of structured, machine-readable content to feed AI models","Websites and landing pages optimized for generative search","Semantic URLs with structured data and machine-friendly language","Advanced schema markup (JSON-LD) for medications","Optimization of FAQs, digital bulas and institutional pages","Topic Authority and AI Citations strategies","Agentic Commerce readiness","Integrated work with marketing, compliance and regulatory","Impact tracking with continuous-evolution metrics"]},{"kind":"heading","level":2,"text":"Monitored AI ecosystem (25+ models and platforms)"},{"kind":"paragraph","text":"We track the leading AI models, platforms and tools in the market, and add emerging models on demand."},{"kind":"kv","pairs":[{"key":"OpenAI","value":"ChatGPT-4o, GPT-5 Nano, GPT-5 Premium, Sora"},{"key":"Anthropic","value":"Claude Sonnet 4 (and Claude family)"},{"key":"Google","value":"Gemini 2.5 Flash, Gemma"},{"key":"Perplexity","value":"Perplexity AI (Sonar)"},{"key":"xAI","value":"Grok 2"},{"key":"Microsoft","value":"Copilot"},{"key":"Meta","value":"Meta AI"},{"key":"Mistral","value":"Mistral (Large and Small)"},{"key":"DeepSeek","value":"DeepSeek (V family)"},{"key":"Alibaba","value":"Qwen"},{"key":"HuggingFace","value":"Hosted open-source models"},{"key":"Ollama","value":"Local open-source models (Kimi, GLM, etc.)"},{"key":"Others","value":"Kling, MCP, Manus, Minimax, Moonshot, V0, Z.ai, Replit Agent"}]},{"kind":"heading","level":2,"text":"Metrics and results"},{"kind":"kv","pairs":[{"key":"AI models monitored daily","value":"25+"},{"key":"Generative searches analyzed per month","value":"5,000,000+"},{"key":"Average AI visibility improvement after 90 days","value":"60%"},{"key":"Time to first actionable findings","value":"First weeks of monitoring"},{"key":"Continuous operation since","value":"2024 (with leading Brazilian pharma labs)"}]},{"kind":"heading","level":3,"text":"Observed results in active projects"},{"kind":"list","items":["Significant increase in product presence in AI responses","Argumentation reflecting the lab's official campaigns and messaging","Better adherence to posology and contraindications stated in the bula","Greater clarity in differentiation against therapeutic alternatives","Reduction of critical mentions identified jointly with compliance teams","60% average increase in product citations in AI conversations within 90 days"]},{"kind":"heading","level":2,"text":"Who it's for (ICP)"},{"kind":"list","items":["Marketing and product managers at pharmaceutical labs needing to understand a new emerging channel and secure strategic presence","Compliance and regulatory teams seeking evidence, traceability and conformity in AI narratives","Medical-scientific areas concerned with the fidelity of medication information in AI responses","Executive leadership needing clear visibility on AI risks and opportunities"]},{"kind":"heading","level":2,"text":"Differentiators"},{"kind":"list","ordered":true,"items":["Pharmaceutical specialization: deep expertise in Brazilian pharma nuances, terminology and regulation.","ANVISA compliance: every strategy strictly follows RDC 96/2008.","Fully managed end-to-end operation: not a SaaS dashboard — from monitoring to corrective action.","Proprietary technology: exclusive methodologies and tools to monitor and influence LLMs at scale.","Coverage of 25+ models: including Brazilian models (Maritaca / Sabiá) and open-source (Mistral, Qwen, DeepSeek, Ollama).","Bilingual PT-BR and EN-US: reports and operation in both languages."]},{"kind":"heading","level":2,"text":"Regulatory compliance (ANVISA)"},{"kind":"paragraph","text":"All GenSearch Me strategies follow ANVISA Resolution RDC 96/2008, which regulates the advertising and informational communication of medications in Brazil. Monitoring includes verifying whether LLM responses about medications comply with this regulation."},{"kind":"list","items":["ANVISA — RDC 96/2008: https://antigo.anvisa.gov.br/legislacao#/visualizar/27813","ANVISA — Medication Advertising: https://www.gov.br/anvisa/pt-br/assuntos/fiscalizacao-e-monitoramento/propaganda","BVSMS — Resolution RDC 96/2008 (full text): https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2008/rdc0096_17_12_2008.html"]},{"kind":"heading","level":2,"text":"Frequently asked questions"},{"kind":"qa","q":"What is pharmaceutical GEO?","a":"Pharmaceutical GEO is the application of Generative Engine Optimization specifically for the pharma industry. It involves monitoring and optimizing how medications are described by generative AI like ChatGPT, Claude, Gemini and Perplexity, ensuring scientific accuracy and ANVISA compliance."},{"kind":"qa","q":"Why does my company need GEO?","a":"Because patients and healthcare professionals are increasingly using generative AI to research medications. If an LLM describes your medication inaccurately, omits important information or recommends competitors more often, it directly impacts sales and reputation."},{"kind":"qa","q":"What is the difference between GEO and SEO?","a":"SEO optimizes for ranking in traditional search engines (Google, Bing), which return link lists. GEO optimizes for AI-generated answers that synthesize information from multiple sources into prose. In GEO there is no 'position 1' — there is 'being accurately cited in the answer'."},{"kind":"qa","q":"How does GenSearch Me's LLM monitoring work?","a":"GenSearch Me sends structured queries to 25+ AI models about medications and therapeutic categories. Responses are analyzed for citation frequency, sentiment, scientific accuracy, regulatory compliance and competitor comparison. Results are delivered in reports with direct evidence."},{"kind":"qa","q":"Are results measurable?","a":"Yes. We use metrics such as AI Share of Voice (mention percentage), Alignment Score (0–100% alignment between the LLM's response and the desired positioning) and sentiment analysis. All with baseline (Zero-Shot Report) and temporal evolution."},{"kind":"qa","q":"How long until I see results?","a":"Relevant findings typically appear within the first weeks of monitoring. The average improvement in AI visibility is 60% after 90 days of continuous operation."},{"kind":"qa","q":"Is the operation ANVISA-compliant?","a":"Yes. Every strategy follows ANVISA Resolution RDC 96/2008, which regulates the advertising and informational communication of medications in Brazil. We even monitor whether LLM responses comply with this regulation."},{"kind":"qa","q":"Do you serve clients outside Brazil?","a":"Yes. The operation is bilingual (PT-BR and EN-US) and serves labs with international presence, with focus on the Brazilian market and expansion to other Portuguese- and English-speaking markets."},{"kind":"heading","level":2,"text":"Site map"},{"kind":"list","items":["Home: https://www.gensearch.me/","About: https://www.gensearch.me/sobre","Services: https://www.gensearch.me/servicos","Blog: https://www.gensearch.me/blog","Glossary (50+ GEO/AEO/AIO terms): https://www.gensearch.me/glossario","FAQ: https://www.gensearch.me/faq","Contact: https://www.gensearch.me/contato","Public reports (Zero-Shot GEO Reports): https://www.gensearch.me/report/"]},{"kind":"heading","level":2,"text":"Contact"},{"kind":"kv","pairs":[{"key":"Email","value":"rodrigo@gensearch.me"},{"key":"Phone","value":"+55 11 96321-9898"},{"key":"Location","value":"São Paulo, SP, Brazil"},{"key":"Website","value":"https://www.gensearch.me"},{"key":"LinkedIn","value":"https://www.linkedin.com/company/gensearch-me"},{"key":"Instagram","value":"https://www.instagram.com/gensearch.me"}]},{"kind":"heading","level":2,"text":"Machine-readable versions for AI / agents"},{"kind":"paragraph","text":"Every public GenSearch Me page has machine-readable Markdown and JSON versions, with no JavaScript, optimized for LLMs, autonomous agents and crawlers. Available in PT-BR (default) and EN-US (.en suffix). Use these URLs whenever possible to consume clean, consistent content."},{"kind":"list","items":["Markdown of this page (EN): https://www.gensearch.me/home.en.md","JSON of this page (EN): https://www.gensearch.me/home.en.json","Markdown of this page (PT-BR): https://www.gensearch.me/home.md","JSON of this page (PT-BR): https://www.gensearch.me/home.json","Full site markdown (every section): https://www.gensearch.me/llms-full.txt","Site summary and map for LLMs: https://www.gensearch.me/llms.txt","Robots.txt: https://www.gensearch.me/robots.txt","Sitemap XML: https://www.gensearch.me/sitemap.xml"]}]}